Great Lakes Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.16M	Buy	67,130 +7,495	+13%	+$585K	0.04%	219
2025 Q4	$4.71M	Hold	59,635	–	–	0.04%	247
2025 Q3	$5.46M	Sell	59,635 -5,168	-8%	-$421K	0.05%	234
2025 Q2	$4.23M	Sell	64,803 -2,033	-3%	-$132K	0.04%	319
2025 Q1	$4.47M	Sell	66,836 -7,391	-10%	-$441K	0.04%	295
2024 Q4	$4.1M	Buy	74,227 +3,591	+5%	+$206K	0.04%	367
2024 Q3	$4.21M	Buy	70,636 +14,555	+26%	+$888K	0.04%	377
2024 Q2	$3.57M	Buy	56,081 +5,359	+11%	+$348K	0.03%	385
2024 Q1	$3.51M	Buy	50,722 +2,470	+5%	+$149K	0.03%	399
2023 Q4	$2.66M	Buy	48,252 +19,378	+67%	+$1.07M	0.03%	426
2023 Q3	$1.68M	Buy	28,874 +6,909	+31%	+$399K	0.02%	469
2023 Q2	$1.18M	Sell	21,965 -30,130	-58%	-$1.34M	0.01%	505
2023 Q1	$2.07M	Buy	+52,095	New	+$2.2M	0.02%	495